Aemetis Inc has a consensus price target of $14.79, established from looking at the 21 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Stifel, and Stifel on March 8, 2024, February 21, 2024, and January 23, 2024. With an average price target of $14.17 between HC Wainwright & Co., Stifel, and Stifel, there's an implied 129.98% upside for Aemetis Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/08/2024 | AMTX | Buy Now | Aemetis | $6.16 | 354.55% | HC Wainwright & Co. | Amit Dayal | → $28 | Reiterates | Buy → Buy | Get Alert |
02/21/2024 | AMTX | Buy Now | Aemetis | $6.16 | 5.52% | Stifel | Derrick Whitfield | $8 → $6.5 | Maintains | Buy | Get Alert |
01/23/2024 | AMTX | Buy Now | Aemetis | $6.16 | 29.87% | Stifel | Derrick Whitfield | $7.5 → $8 | Maintains | Buy | Get Alert |
01/23/2024 | AMTX | Buy Now | Aemetis | $6.16 | -43.18% | Truist Securities | Jordan Levy | $5 → $3.5 | Maintains | Hold | Get Alert |
11/27/2023 | AMTX | Buy Now | Aemetis | $6.16 | 21.75% | Stifel | Derrick Whitfield | $10 → $7.5 | Maintains | Buy | Get Alert |
09/15/2023 | AMTX | Buy Now | Aemetis | $6.16 | 354.55% | HC Wainwright & Co. | Amit Dayal | → $28 | Reiterates | Buy → Buy | Get Alert |
08/22/2023 | AMTX | Buy Now | Aemetis | $6.16 | 70.45% | Stifel | Derrick Whitfield | $9 → $10.5 | Maintains | Buy | Get Alert |
08/16/2023 | AMTX | Buy Now | Aemetis | $6.16 | 70.45% | UBS | Manav Gupta | $2.5 → $10.5 | Upgrade | Neutral → Buy | Get Alert |
08/04/2023 | AMTX | Buy Now | Aemetis | $6.16 | 354.55% | HC Wainwright & Co. | Amit Dayal | → $28 | Reiterates | Buy → Buy | Get Alert |
07/07/2023 | AMTX | Buy Now | Aemetis | $6.16 | 54.22% | Stifel | Derrick Whitfield | $9 → $9.5 | Maintains | Buy | Get Alert |
06/06/2023 | AMTX | Buy Now | Aemetis | $6.16 | -51.3% | Piper Sandler | Ryan Todd | $2 → $3 | Maintains | Underweight | Get Alert |
04/27/2023 | AMTX | Buy Now | Aemetis | $6.16 | 46.1% | Stifel | Derrick Whitfield | $10 → $9 | Maintains | Buy | Get Alert |
04/14/2023 | AMTX | Buy Now | Aemetis | $6.16 | 62.34% | Stifel | Derrick Whitfield | $18 → $10 | Maintains | Buy | Get Alert |
04/13/2023 | AMTX | Buy Now | Aemetis | $6.16 | -59.42% | Truist Securities | Jordan Levy | $5 → $2.5 | Maintains | Hold | Get Alert |
02/28/2023 | AMTX | Buy Now | Aemetis | $6.16 | -51.3% | Piper Sandler | Ryan Todd | → $3 | Initiates | → Underweight | Get Alert |
02/01/2023 | AMTX | Buy Now | Aemetis | $6.16 | -18.83% | Truist Securities | Jordan Levy | $9 → $5 | Maintains | Hold | Get Alert |
12/14/2022 | AMTX | Buy Now | Aemetis | $6.16 | -31.01% | UBS | Manav Gupta | → $4.25 | Initiates | → Neutral | Get Alert |
08/09/2022 | AMTX | Buy Now | Aemetis | $6.16 | 94.81% | Truist Securities | Jordan Levy | → $12 | Downgrade | Buy → Hold | Get Alert |
06/13/2022 | AMTX | Buy Now | Aemetis | $6.16 | 338.31% | Credit Suisse | Manav Gupta | $35 → $27 | Maintains | Outperform | Get Alert |
The latest price target for Aemetis (NASDAQ: AMTX) was reported by HC Wainwright & Co. on March 8, 2024. The analyst firm set a price target for $28.00 expecting AMTX to rise to within 12 months (a possible 354.55% upside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for Aemetis (NASDAQ: AMTX) was provided by HC Wainwright & Co., and Aemetis reiterated their buy rating.
The last upgrade for Aemetis Inc happened on August 16, 2023 when UBS raised their price target to $10.5. UBS previously had a neutral for Aemetis Inc.
The last downgrade for Aemetis Inc happened on August 9, 2022 when Truist Securities changed their price target from N/A to $12 for Aemetis Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aemetis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aemetis was filed on March 8, 2024 so you should expect the next rating to be made available sometime around March 8, 2025.
While ratings are subjective and will change, the latest Aemetis (AMTX) rating was a reiterated with a price target of $0.00 to $28.00. The current price Aemetis (AMTX) is trading at is $6.16, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.